Valproic acid Completed Phase 2 Trials for Myelodysplastic Syndromes (MDS) / Acute Myeloid Leukemia (AML) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT003391965-azacytidine Valproic Acid and ATRA in AML and High Risk MDS